medigraphic.com
Órgano Oficial del Instituto Nacional de Pediatría

2023, Número 6

<< Anterior Siguiente >>

Acta Pediatr Mex 2023; 44 (6)


Caracterización clínico-epidemiológica de pacientes pediátricos con COVID-19 atendidos en un hospital regional de El Salvador

Saravia HKC, Flores KE, Oliva MJE, Sánchez GMA, Domínguez QRL

Idioma: Español
Referencias bibliográficas: 53
Paginas: 419-431
Archivo PDF: 256.04 Kb.


RESUMEN

Objetivo: Describir las características epidemiológicas, clínicas, de laboratorio, imagen y tratamiento de casos pediátricos de COVID-19, confirmados por reacción en cadena de polimerasa-transcriptasa reversa (RT-PCR) o serología, atendidos en un hospital regional de El Salvador.
Material y Método: Estudio transversal y descriptivo de pacientes pediátricos con COVID-19, confirmados con pruebas moleculares o serología atendidos entre el 1 de junio y el 31 de diciembre de 2020. Para asegurar la confidencialidad se asignó un código por paciente.
Resultados: Se estudiaron 72 pacientes entre los que predominó el grupo de 1 a 4 años (n = 25). La media de edad fue de 3.4 años; 28 de sexo femenino y 44 del masculino. Permanecieron asintomáticos 3 pacientes, 37 con síntomas leves, 22 moderados, 4 graves y 6 críticos. Los síntomas más frecuentes fueron: fiebre, hiporexia, adinamia y tos. Los hallazgos de laboratorio de mayor reporte fueron: anemia, linfopenia, deshidrogenasa láctica, proteína C reactiva y velocidad de eritrosedimentación elevadas. En la radiografía de tórax se encontró neumonía en 26 pacientes. Tratamientos más indicados: antibióticos y acetaminofén. Once pacientes requirieron oxígeno suplementario y siete ventilación mecánica. La estancia hospitalaria en menores de 1 año fue del doble con respecto a los otros grupos etarios. Seis pacientes resultaron con síndrome inflamatorio multisistémico. Hubo siete fallecimientos.
Conclusiones: Si bien en la mayoría de los casos el pronóstico fue favorable, algunos pacientes tuvieron enfermedad grave o crítica y fallecieron a pesar de su atención en cuidados intensivos. Para disminuir estos desenlaces se requiere educar a la población a fin de que acuda rápidamente a consulta, fortalecer las competencias clínicas del personal de salud para la identificación oportuna de la enfermedad e incrementar la capacidad instalada de cuidados intensivos ante fenómenos epidemiológicos similares.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. World Health Organization. Coronavirus disease (COVID-19) pandemic. Geneva (CH): World Health Organization, 2022. https://www.who.int/emergencies/diseases/novel-coronavirus-2019 adgroupsurvey{adgroupsurvey}&gclid=Cj0KCQjwhLKUBhDiARIsAMaTLnEW8xXi4_sywpOtmPBzMd0YAKD8FwcGpmlSVjCuU7BEAFV3-Rk5ax-AaArajEALw_wcB

  2. World Health Organization. WHO Coronavirus (COVID-19)Dashboard. Geneva (CH): World Health Organization, 2022.https://covid19.who.int/?gclid=Cj0KCQjwlOmLBhCHARIsAGiJg7mwYVOy6SDAWogC5R3qu85k9QODCcxHQrrspmostTPJjsganhJBb68aAng_EALw_wcB

  3. Dong Y, Mo X, Hu Y, Qi X, Jiang F, Jiang Z, et al. Epidemiologyof COVID-19 among children in China. Pediatrics 2020; 145(6): e20200702. doi: 10.1542/peds.2020-0702

  4. Shen KL, Yang YH, Jiang RM, Wang TY, Zhao DC, Jiang Y, et al.Updated diagnosis, treatment, and prevention of COVID-19in children: experts' consensus statement (condensed versionof the second edition). World J Pediatr 2020; 16 (3):232-39. doi: 10.1007/s12519-020-00362-4

  5. Tagarro A, Epalza C, Santos M, Sanz-Santaeufemia FJ, OtheoE, Moraleda C, et al. Screening and severity of CoronavirusDisease 2019 (COVID-19) in children in Madrid, Spain.JAMA Pediatr 2020; e201346. doi: 10.1001/jamapediatrics.2020.1346

  6. Son MB. COVID-19: Multisystem inflammatory syndromein children (MIS-C) management and outcome. Alphenaan den Rijn, (NL): UpToDate; 2023. https://www.uptodate.com/contents/covid-19-multisystem-inflammatorysyndrome-in-children-mis-c-management-and-outcome

  7. Bhowmick R, Gulla KM. Pediatric Acute Respiratory DistressSyndrome in COVID-19 Pandemic: Is it the Puzzle ofthe Century? Indian J Crit Care Med 2022; 26 (3): 264-65.doi:10.5005/jp-journals-10071-24175

  8. Kornitzer J. A Systematic Review of Characteristics Associatedwith COVID-19 in Children with Typical Presentationand with Multisystem Inflammatory Syndrome. Int J EnvironRes Public Health 2021; 18 (16): 8269. doi:10.3390/ijerph18168269

  9. Antoon JW, Hall M, Howard LM, Herndon A, FreundlichKL, Grijalva CG. COVID-19 and Acute Neurologic Complicationsin Children. Pediatrics 2022; 150 (5): e2022058167.doi:10.1542/peds.2022-058167

  10. Hoang A. COVID-19 in 7780 pediatric patients: A systematicreview. EClinicalMedicine 2020; 24: 100433. doi: 10.1016/j.eclinm.2020.100433

  11. Bustos BR, Padilla PO. El tiempo de llene capilar prolongadoes predictor de una saturación venosa central deoxígeno disminuida. Rev Chil Pediatría 2014; 85 (5): 539-45.doi:10.4067/S0370-41062014000500003

  12. Jain S, Iverson LM. Glasgow Coma Scale. In: StatPearls.Treasure Island (FL): StatPearls Publishing, 2022.

  13. Ministerio de Salud. Lineamientos técnicos para la atenciónintegral de personas con COVID-19. Segunda edición. Ministeriode Salud, 2020. http://asp.salud.gob.sv/regulacion/pdf/lineamientos/lineamientos_tecnicos_atencion_integral_codiv19_segunda_edicion_adenda_acuerdo_1949.pdf

  14. Acevedo L, Piñeres-Olave BE, Niño-Serna LF, Vega LM,Gomez IJA, Chacón S, et al. Mortality and clinical characteristicsof multisystem inflammatory syndrome in children(MIS-C) associated with covid-19 in critically ill patients: anobservational multicenter study (MISCO study). BMC Pediatr2021; 21 (1): 516. doi: 10.1186/s12887-021-02974-9

  15. Gonzalez-Dambrauskas S, Vasquez-Hoyos P, CamporesiA, Cantillano EM, Dallefeld S, Dominguez-Rojas J, et al.Critical Coronavirus and Kids Epidemiological (CAKE) StudyInvestigators. Paediatric critical COVID-19 and mortality ina multinational prospective cohort. Lancet Reg Health Am2022: 100272. doi: 10.1016/j.lana.2022.100272

  16. Feldstein LR, Rose EB, Horwitz SM, Collins JP, NewhamsMM, Son MBF, et al. Multisystem Inflammatory Syndromein U.S. Children and Adolescents. N Engl J Med 2020; 383(4): 334-46. doi:10.1056/NEJMoa2021680

  17. Rubens JH, Akindele NP, Tschudy MM, Sick-Samuels AC.Acute covid-19 and multisystem inflammatory syndromein children. BMJ 2021: n385. doi:10.1136/bmj.n385

  18. American Academy of Pediatrics. Children and COVID-19:State-Level Data Report. Itasca (IL): American Academy ofPediatrics; 2022. https://www.aap.org/en/pages/2019-novel-coronavirus-covid-19-infections/children-and-covid-

  19. 19-state-level-data-report/19. Dewi R, Kaswandani N, Karyanti MR, Setyanto DB, PudjiadiAH, Hendarto A, et al. Mortality in children with positiveSARS-CoV-2 polymerase chain reaction test: Lessonslearned from a tertiary referral hospital in Indonesia. Int JInfect Dis 2021; 107: 78-85. doi: 10.1016/j.ijid.2021.04.019

  20. Whittaker E, Bamford A, Kenny J, Kaforou M, Jones CE,Shah P, et al. Clinical characteristics of 58 children with apediatric inflammatory multisystem syndrome temporallyassociated with SARS-CoV-2. JAMA 2020; 324 (3): 259. doi:10.1001/jama.2020.10369

  21. Ouldali N, Pouletty M, Mariani P, Beyler C, Blachier A,Bonacorsi S, et al. Emergence of Kawasaki disease relatedto SARS-CoV-2 infection in an epicentre of the FrenchCOVID-19 epidemic: a time-series analysis. Lancet ChildAdolesc Health 2020; 4 (9): 662-8. doi: 10.1016/S2352-4642(20)30175-9

  22. Swann OV, Holden KA, Turtle L, Pollock L, Fairfield CJ, DrakeTM, et al. Clinical characteristics of children and youngpeople admitted to hospital with Covid-19 in United Kingdom:prospective multicentre observational cohort study.BMJ 2020; m3249. doi: 10.1136/bmj.m3249

  23. Cifuentes MP, Rodriguez-Villamizar LA, Rojas-Botero ML,Alvarez-Moreno CA, Fernández-Niño JA. Socioeconomicinequalities associated with mortality for COVID-19 inColombia: a cohort nationwide study. J Epidemiol CommunityHealth 2021; 75 (7): 610-15. doi:10.1136/jech-2020-216275

  24. Mena GE, Martinez PP, Mahmud AS, Marquet PA, BuckeeCO, Santillana M. Socioeconomic status determinesCOVID-19 incidence and related mortality in Santiago,Chile. Science 2021; 372 (6545): eabg5298. doi:10.1126/science.abg5298

  25. Zampieri FG, Skrifvars MB, Anstey J. Intensive care accessibilityand outcomes in pandemics. Intensive Care Med2020; 46 (11): 2064-66. doi:10.1007/s00134-020-06264-3

  26. Silva LL. Emergency care gap in Brazil: geographical accessibilityas a proxy of response capacity to tackle COVID-19. Front Public Health 2021; 9: 740284. doi:10.3389/fpubh.2021.740284

  27. Levy M, Recher M, Hubert H, Javouhey E, Fléchelles O,Leteurtre S, et al. Multisystem Inflammatory Syndromein children by COVID-19 vaccination status of adolescentsin France. JAMA 2022; 327 (3): 281-83. doi: 10.1001/jama.2021.23262

  28. Payne AB, Gilani Z, Godfred-Cato S, Belay ED, Feldstein LR,Patel MM, et al. Incidence of multisystem inflammatorysyndrome in children among US persons infected withSARS-CoV-2. JAMA Netw Open 2021; 4 (6): e2116420. doi:10.1001/jamanetworkopen.2021.16420

  29. Feldstein LR, Tenforde MW, Friedman KG, Newhams M,Rose EB, Dapul H, et al. Characteristics and outcomes of USchildren and adolescents with Multisystem InflammatorySyndrome in Children (MIS-C) compared with severe acuteCOVID-19. JAMA 2021; 325 (11): 1074-87. doi: 10.1001/jama.2021.2091

  30. Centers for Disease Control and Prevention. Informationfor Healthcare Providers about Multisystem InflammatorySyndrome in Children (MIS-C) [Internet].Atlanta (GA): Centers for Disease Control and Prevention;2021. https://www.cdc.gov/mis/mis-c/hcp/index.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fmis%2Fhcp%2Findex.html

  31. Centers for Disease Control and Prevention. COVID-19Response Team. Coronavirus disease 2019 in children.United States, February 12-April 2, 2020. Morbidity andMortality Weekly Report 422 MMWR 2020; 69 (14): 422-6. https://www.cdc.gov/mmwr/volumes/69/wr/pdfs/mm6914e4-H.pdf

  32. Seth S, Rashid F, Khera K. An overview of the COVID‐19complications in paediatric population: A pandemic dilemma.Int J Clin Pract 2021; 75 (9). doi:10.1111/ijcp.14494

  33. Siebach MK, Piedimonte G, Ley SH. COVID‐19 in childhood:transmission, clinical presentation, complicationsand risk factors. Pediatr Pulmonol 2021; 56 (6): 1342-56.doi:10.1002/ppul.25344

  34. Siracusa L, Cascio A, Giordano S, Medaglia AA, Restivo GA,Pirrone I, et al. Neurological complications in pediatricpatients with SARS-CoV-2 infection: a systematic review ofthe literature. Ital J Pediatr 2021; 47 (1): 123. doi:10.1186/s13052-021-01066-9

  35. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinicalcharacteristics of 138 hospitalized patients with 2019 novelcoronavirus-infected pneumonia in Wuhan, China. JAMA2020; 323 (11): 1061-69. doi: 10.1001/jama.2020.1585

  36. Kelada M, Anto A, Dave K, Saleh SN. The role of sex in therisk of mortality from COVID-19 amongst adult patients:a systematic review. Cureus 2020; 12 (8): e10114. doi:10.7759/cureus.10114

  37. Lu X, Zhang L, Du H, Zhang J, Li YY, Qu J, et al. SARS-CoV-2infection in children. N Engl J Med 2020; 382 (17): 1663-5.doi: 10.1056/NEJMc2005073

  38. Götzinger F, Santiago-García B, Noguera-Julián A, LanaspaM, Lancella L, Caló Carducci FI, et al. COVID-19 in childrenand adolescents in Europe: a multinational, multicentrecohort study. Lancet Child Adolesc Health. 2020; 4(9):653-661. doi: 10.1016/S2352-4642(20)30177-2

  39. Zhu L, Wang J, Huang R, Liu L, Zhao H, Wu C, et al. Clinicalcharacteristics of a case series of children with coronavirusdisease 2019. Pediatr Pulmonol 2020; 55 (6): 1430-32. doi:10.1002/ppul.24767

  40. Katz J, Guelmann M. Increased prevalence of dysgeusia inpediatric patients diagnosed with COVID-19. Pediatr Dent2021; 43 (4): 282-84. PMID: 34467844

  41. Yan Q, Qiu D, Liu X, Guo X, Hu Y. Prevalence of smell ortaste dysfunction among children with COVID-19 infection:a systematic review and meta-analysis. Front Pediatr 2021;9: 686600. doi: 10.3389/fped.2021.686600

  42. Mania A, Mazur-Melewska K, Lubarski K, Kuczma-NapierałaJ, Mazurek J, Jończyk-Potoczna K, et al. Wide spectrum ofclinical picture of COVID-19 in children -From mild to severedisease. J Infect Public Health 2021; 14 (3): 374-79. doi:10.1016/j.jiph.2020.12.029

  43. Epidemiology Working Group for NCIP Epidemic Response,Chinese Center for Disease Control and Prevention. Theepidemiological characteristics of an outbreak of 2019novel coronavirus diseases (COVID-19) in China. ZhonghuaLiu Xing Bing Xue Za Zhi 2020; 41 (2): 145-51. doi: 10.3760/cma.j.issn.0254-6450.2020.02.003

  44. Kosmeri C, Koumpis E, Tsabouri S, Siomou E, Makis A.Hematological manifestations of SARS‐CoV‐2 in children.Pediatr Blood Cancer 2020; 67 (12). doi:10.1002/pbc.28745

  45. Wardlaw T, Salama P, Johansson EW, Mason E. Pneumonia:the leading killer of children. Lancet 2006; 368 (9541):1048-50. doi: 10.1016/S0140-6736(06)69334-3

  46. Wang Z, Li X, Li D, Li Y. Clinical features of 167 childrenwith the novel influenza A (H1N1) virus infection inXian, China. Turk J Pediatr 2012; 54 (2): 99-104. PMID:22734294

  47. Babyn PS, Chu WC, Tsou IY, Wansaicheong GK, Allen U,Bitnun A, et al. Severe acute respiratory syndrome (SARS):chest radiographic features in children. Pediatr Radiol 2004;34 (1): 47-58. doi: 10.1007/s00247-003-1081-8

  48. Prata-Barbosa A, Lima-Setta F, Santos GRD, Lanziotti VS,de Castro REV, de Souza DC, et al. Pediatric patients withCOVID-19 admitted to intensive care units in Brazil: a prospectivemulticenter study. J Pediatr (Rio J) 2020; 96 (5):582-92. doi: 10.1016/j.jped.2020.07.002

  49. Shekerdemian LS, Mahmood NR, Wolfe KK, Riggs BJ, RossCE, McKiernan CA, et al. Characteristics and outcomes ofchildren with coronavirus disease 2019 (COVID-19) infectionadmitted to US and Canadian pediatric intensive careunits. JAMA Pediatr 2020; 174 (9): 868-73. doi: 10.1001/jamapediatrics.2020.1948

  50. Liu X, Tang J, Xie R, Li W, Chen J, Guo Y, et al. Clinical andepidemiological features of 46 children <1-year-old withcoronavirus disease 2019 in Wuhan, China: a descriptivestudy. J Infect Dis 2020; 222 (8): 1293-97. doi: 10.1093/infdis/jiaa472

  51. Zhang C, Gu J, Chen Q, Deng N, Li J, Huang L, et al. Clinicaland epidemiological characteristics of pediatric SARSCoV-2 infections in China: a multicenter case series.PLoS Med 2020; 17 (6): e1003130. doi: 10.1371/journal.pmed.1003130

  52. Guo CX, He L, Yin JY, Meng XG, Tan W, Yang GP, et al. Epidemiologicaland clinical features of pediatric COVID-19.BMC Med 2020; 18 (1): 250. doi: 10.1186/s12916-020-01719-2

  53. Garazzino S, Montagnani C, Doná D, Meini A, Felici E,Vergine G, et al. Multi-centre Italian study of SARS-CoV-2infection in children and adolescents, preliminary data asat 10 April 2020. Euro Surveill 2020; 25 (18): 2000600. doi:10.2807/1560-7917.ES.2020.25.18.200600




2020     |     www.medigraphic.com